Century Therapeutics reports preliminary Q4 2024 cash of ~$220M

Century Therapeutics, Inc.

As of Dec 31, 2024, cash, cash equivalents and investments approx $220M.
Preliminary, unaudited; subject to change upon completion of year-end closing procedures.
Full year 2024 financial results to be included in upcoming Form 10-K.

item 2.02 item 7.01 item 9.01

Century Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-25-002841

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.